Priya Singhal - Net Worth and Insider Trading

Priya Singhal Net Worth

The estimated net worth of Priya Singhal is at least $1 Million dollars as of 2024-04-28. Priya Singhal is the Head of Development of Biogen Inc and owns about 4,886 shares of Biogen Inc (BIIB) stock worth over $1 Million. Details can be seen in Priya Singhal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Priya Singhal has not made any transactions after 2024-04-02 and currently still holds the listed stock(s).

Transaction Summary of Priya Singhal

To

Priya Singhal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Priya Singhal owns 2 companies in total, including Larimar Therapeutics Inc (LRMR) , and Biogen Inc (BIIB) .

Click here to see the complete history of Priya Singhal’s form 4 insider trades.

Insider Ownership Summary of Priya Singhal

Ticker Comapny Transaction Date Type of Owner
LRMR Larimar Therapeutics Inc 2019-03-04 See Remarks
BIIB Biogen Inc 2024-04-02 Head of Development

Priya Singhal Latest Holdings Summary

Priya Singhal currently owns a total of 1 stock. Priya Singhal owns 4,886 shares of Biogen Inc (BIIB) as of April 2, 2024, with a value of $1 Million.

Latest Holdings of Priya Singhal

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BIIB Biogen Inc 2024-04-02 4,886 208.90 1,020,685

Holding Weightings of Priya Singhal


Priya Singhal Form 4 Trading Tracker

According to the SEC Form 4 filings, Priya Singhal has made a total of 10 transactions in Biogen Inc (BIIB) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Biogen Inc is the sale of 93 shares on April 2, 2024, which brought Priya Singhal around $19,817.

Insider Trading History of Priya Singhal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Priya Singhal Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Priya Singhal Ownership Network

Ownership Network List of Priya Singhal

No Data

Ownership Network Relation of Priya Singhal


Priya Singhal Owned Company Details

What does Larimar Therapeutics Inc do?

Who are the key executives at Larimar Therapeutics Inc?

Priya Singhal is the See Remarks of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .

Larimar Therapeutics Inc (LRMR) Insider Trades Summary

Over the past 18 months, Priya Singhal made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 5,000 shares made by Michael Celano , and a net purchase of 5,000 shares made by Carole Ben-maimon .

In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 4,292,617 shares, with a net purchase of 4,292,617 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,310,367 shares were bought by its insiders, resulting in a net purchase of 4,310,367 shares.

Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Larimar Therapeutics Inc Insider Transactions

No Available Data

Priya Singhal Mailing Address

Above is the net worth, insider trading, and ownership report for Priya Singhal. You might contact Priya Singhal via mailing address: C/o Zafgen, Inc., 175 Portland Street 4th Fl, Boston Ma 02114.

Discussions on Priya Singhal

No discussions yet.